Compare Roblox Corp (RBLX) vs Tempus AI (TEM) Price & Performance
Price performance (Past 24H)
Key statistics
Key statistics
Roblox Corp vs Tempus AI — how do they compare? Roblox Corp trades at $45.72 (market cap $33.15B), while Tempus AI trades at $70.05 (market cap $12.77B). The key difference: Roblox Corp is far larger — about 2.6× Tempus AI's market cap, and Tempus AI is trading nearer its 52-week high, Roblox Corp nearer its low. Which is the better fit depends on your goals — on Pluang, investors hold Roblox Corp for 93 Days and Tempus AI for 22 Days on average.
| RBLX | TEM | |
|---|---|---|
Market Cap | $33.15B | $12.77B |
Volume | 12,598,314 | 8,980,490 |
Sector | Technology | Broad Market / Factor |
52-Week High | $138.56 | $99.28 |
52-Week Low | $35.54 | $41.55 |
Typical Hold Time | 93 Days | 22 Days |
Enterprise Value | $31.98B | $13.40B |
Aura AI Summary
Signals from Pluang's Aura AI — not financial advice
Aura AI Summary
Signals from Pluang's Aura AI — not financial advice
Roblox trades at $45.53, down slightly by 0.07% today, following recent volatility driven by mixed analyst sentiment. The stock shows strong revenue growth with 2025 revenue reaching $4.89 billion, though it remains unprofitable with a net income margin of -17.61%. Recent technical indicators suggest a bullish trend with moving averages supporting upside momentum, while oscillators remain neutral. The company continues to beat earnings expectations, with Q2 2026 EPS of -$0.26 surpassing estimates of -$0.34.
Roblox presents a growth story with expanding revenue and improving cash flow, but profitability challenges persist. The consensus price target of $50.85 suggests 12% upside potential, though recent Jefferies downgrade highlights concerns about bookings growth. Key risks include continued losses, competitive pressures, and execution challenges in monetizing its user base effectively.
Tempus AI (TEM) trades at $70.29, down 2.35% on the day, with a bullish technical signal despite negative profitability. Recent FDA clearance for its ECG-MR AI product and 13 abstracts accepted for ESMO Congress 2026 highlight ongoing innovation. Revenue grew to $1.4B in 2026, though net losses persist. The stock shows strong analyst support with a $72.60 consensus target and 64% buy ratings.
Outlook remains cautiously optimistic driven by AI healthcare adoption and data licensing growth, but high valuation multiples and sustained losses pose risks. Investor sentiment is positive amid recent insider selling and institutional interest, yet profitability challenges and competitive pressures require monitoring for long-term value creation.
Returns comparison
Trailing returns across standard periods
Returns comparison
Trailing returns across standard periods
Investor sentiment on Pluang
What Pluang investors did over the last 30 days
Investor sentiment on Pluang
What Pluang investors did over the last 30 days
Top news
Latest headlines on both assets
Top news
Latest headlines on both assets
About Roblox Corp
Roblox operates an online video game platform that lets young gamers create, develop, and monetize games (or experiences) for other players. The firm effectively offers its developers a hybrid of a game engine, publishing platform, online hosting and services, marketplace with payment processing, and social network. The platform is a closed garden that Roblox controls, earning revenue in multiple places while benefiting from outsourced game development. Unlike traditional video game publishers, Roblox is more focused on the creation of new tools and monetization techniques for its developers then creating new games or franchises. Roblox is increasingly focused on creating a metaverse that moves beyond games toward experiences like concerts, education, and even business management.
Read more on RBLX →About Tempus AI
Tempus AI Inc is a technology company. It has built the Tempus Platform, which comprises both a technology platform to free healthcare data from silos and an operating system to make the resulting data useful. Its Intelligent Diagnostics use AI, including generative AI, to make laboratory tests more accurate, tailored, and personal.
Read more on TEM →
